Skin disorders, Guidance

Applied filters

Care Setting (2)
- Paediatrics and neonates (2)
- Primary Care (1)
Guidance (80)
- Advanced therapy medicinal products (4)
- Adverse effects (2)
- Excipients (1)
- Porphyria (1)
- Safety in Breastfeeding (73)
- Stability in dosette boxes (26)
- Stability outside the fridge (8)
Medicine (76)
- Aciclovir (1)
- Acitretin (2)
- Adalimumab (1)
- Adapalene (1)
- Alitretinoin (2)
- Aminolevulinic acid hydrochloride (1)
- Amorolfine (1)
- Azathioprine (1)
- Azelaic acid (1)
- Beclometasone (1)
- Benzoyl peroxide (1)
- Benzyl benzoate (1)
- Betamethasone (1)
- Calcipotriol (1)
- Calcitriol (1)
- Cetrimide (1)
- Chlorhexidine (1)
- Ciclosporin (1)
- Clindamycin (2)
- Clotrimazole (1)
- Co-cyprindiol (1)
- Coal tar (1)
- Cyclomethicone + Isopropyl myristate (1)
- Dapsone (1)
- Diclofenac sodium (2)
- Dimethyl fumarate (1)
- Dimeticone (2)
- Doxepin (1)
- Doxycycline (1)
- Econazole (1)
- Erythromycin (2)
- Etanercept (1)
- Fluocinolone acetonide (1)
- Fluorouracil (1)
- Fluticasone (1)
- Fusidic acid (1)
- Glycopyrronium (1)
- Griseofulvin (1)
- Hydrocortisone (1)
- Hydrogen peroxide (1)
- Ibuprofen (1)
- Ichthammol (1)
- Imiquimod (1)
- Industrial methylated spirit (1)
- Infliximab (1)
- Isotretinoin (3)
- Ivermectin (1)
- Ketoconazole (1)
- Levomenthol (1)
- Lymecycline (1)
- Malathion (2)
- Meloxicam (1)
- Methotrexate (1)
- Methyl aminolevulinate (1)
- Metronidazole (1)
- Miconazole (1)
- Minoxidil (1)
- Mometasone (1)
- Mupirocin (1)
- Naproxen (1)
- Neomycin (1)
- Nicotinamide (1)
- Nystatin (1)
- Polymyxin B + Bacitracin (1)
- Potassium permanganate (1)
- Povidone (1)
- Propofol (1)
- Rituximab (1)
- Ruxolitinib (1)
- Salicylic acid (1)
- Selenium (1)
- Silver nitrate (1)
- Sirolimus (1)
- Sodium chloride (1)
- Soya oil (1)
- Tacrolimus (1)
- Tazarotene (1)
- Terbinafine (1)
- Titanium dioxide + Titanium peroxide + Titanium salicylate (1)
- Tretinoin (3)
- Triamcinolone acetonide (1)
- Ustekinumab (1)
Planning (34)
- Biosimilars (4)
- New Medicines (26)
  - CCG commissioned new medicines (19)
  - NHS England commissioned new medicines (11)
  - Pre-registration new medicines (UK/EU) (2)
- Patent expiries (20)
Specialty (80)
- Allergy and immunology (6)
- Anaesthesia and pain (2)
- Cancers (10)
- Cardiovascular system disorders (2)
- Ear, nose and throat disorders (15)
- Endocrine system disorders (3)
- Eyes and vision (11)
- Gastrointestinal disorders (4)
- Haematological disorders (4)
- Infection and infectious diseases (14)
- Mental health and illness (1)
- Musculo-skeletal disorders (9)
- Neurological disorders (1)
- Nutritional and metabolic disorders (3)
- Obstetrics and gynaecology (2)
- Respiratory disorders (6)
- Skin disorders (80)
- Wounds and injuries (1)

Autologous human keratinocytes

31 August 2021dm+d: Unassigned

What issues should be considered in patients with peanut allergy requiring a medicine containing soya?

16 October 2020Peanut and soya belong to the same plant family, so there is concern about cross-sensitivity. This Medicines Q&A (updated April 2020) discusses the issues to…

How should head lice be treated in a breastfeeding mother?

12 March 2020Wet combing or dimeticone may be used to treat head lice in breastfeeding mothers. Malathion may be used as an alternative if a traditional insecticide…

What is the most suitable treatment for acne in a person with acute porphyria?

10 January 2020Topical (applied to the skin) treatments for acne are considered to be safer than oral treatments in people with an acute form of porphyria, provided…

Do NSAIDs increase the risk of severe skin reactions in children with chickenpox?

1 October 2019This Q&A evaluates the limited published evidence investigating an association between Non-steroidal anti-inflammatory drugs (NSAIDs) and severe skin reactions in children with chickenpox.

Beremagene geperpavec

2 July 2019dm+d: Unassigned

Adalimumab

26 February 2016dm+d: 398728003

Etanercept

22 February 2016dm+d: 118259007

SPS - Specialist Pharmacy Service

NHS

Skin disorders, Guidance

80 results